by Neoteryx | 3 min read
The healthcare industry worldwide will experience significant changes in 2021, but in some parts of the world, these changes began before the onset of the coronavirus pandemic. Even as the …
Read Storyby Neoteryx | 4 min read
Routine blood sampling is critical to identifying health problems early, and helping care providers make appropriate treatment interventions. That's why doctors recommend going for a blood test at least once …
Read Storyby Neoteryx | 5 min read
Times have changed, and so has the average healthcare consumer. Today’s consumers are more inclined toward digital health solutions, particularly the younger generations. A survey from Accenture found millennials (born …
Read Storyby Neoteryx | 4 min read
What is occupational exposure? Millions of people are exposed to chemicals or other hazardous materials in their workplace every day. If not handled safely, these hazards can cause health problems …
Read Storyby Neoteryx | 3 min read
Advances in blood analysis technology enable researchers to identify possible biomarkers of health conditions before the onset of symptoms through a maternal fetal blood test. One such condition is pre-eclampsia …
Read Storyby Neoteryx | 4 min read
Recent studies show that people with type A blood may be more susceptible to COVID-19 illness than those with other blood types. Researchers in China reached this conclusion after studying …
Read StoryLearn about insights, research, case studies, and tutorials on integrating remote specimen collection, microsampling, and more!
© Neoteryx 2021 | Privacy Policy | Sitemap
421 Amapola Ave
Torrance, CA 90501
This site is protected by reCAPTCHA and the Google Privacy
Policy and Terms of Service apply.
Mitra® devices are intended as a specimen collector and for the storage and transport of biological fluids. They are CE-IVD self-certified in the UK and EU, a Class 1 IVD in Australia, Brazil & China, Class B in South Africa, and registered with health agencies in Canada, Thailand, and Ukraine. In the United States, Mitra devices are for Research Use Only (RUO). In some countries, Mitra devices may be used in clinical diagnostic laboratory systems after the laboratory has validated their complete system in compliance with relevant rules and regulations. Mitra is a registered trademark of Neoteryx, LLC.
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research use only (RUO) and not for therapeutic or diagnostic use. hemaPEN® is a registered trademark owned by Trajan Scientific Australia Pty Ltd.
Copyright © 2022 Neoteryx, LLC, Part of the Trajan Family. All rights reserved.